Cargando…

Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program

OBJECTIVE: Obesity is a growing global concern compounded by limited availability of effective treatment options. The SURMOUNT development program aims to evaluate the efficacy and safety of tirzepatide as an adjunct to lifestyle intervention compared with placebo on chronic weight management in adu...

Descripción completa

Detalles Bibliográficos
Autores principales:	le Roux, Carel W., Zhang, Shuyu, Aronne, Louis J., Kushner, Robert F., Chao, Ariana M., Machineni, Sriram, Dunn, Julia, Chigutsa, Farai B., Ahmad, Nadia N., Bunck, Mathijs C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107501/ https://www.ncbi.nlm.nih.gov/pubmed/36478180 http://dx.doi.org/10.1002/oby.23612

Ejemplares similares

Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
por: Wadden, Thomas A., et al.
Publicado: (2023)

OR10-05 Improved Mental And Psychosocial Patient-Reported Outcomes Among People With Obesity Treated With Tirzepatide: Results From SURMOUNT-1 Study
por: Poon, Jiat Ling, et al.
Publicado: (2023)

SAT660 Predictors Of Achieving Body Weight Reduction ≥20% With Tirzepatide In People With Overweight Or Obesity In SURMOUNT-1
por: Srinath, Reshmi, et al.
Publicado: (2023)

SAT658 Tirzepatide Reduces The Predicted Risk Of Developing Atherosclerotic Cardiovascular Disease: A Post-hoc Analysis Of The Surmount-1 Trial
por: Hankosky, Emily R, et al.
Publicado: (2023)

Advent of tirzepatide: boon for diabetic and obese?
por: Bhusal, Amrit
Publicado: (2023)

Proposals for Surmounting Sensor Noises
por: Pittella, Andre, et al.
Publicado: (2023)

Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity
por: Quddos, Fatima, et al.
Publicado: (2023)

Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
por: Sinha, Rachel, et al.
Publicado: (2023)

Tirzepatide: A Systematic Update
por: Forzano, Imma, et al.
Publicado: (2022)

Adverse Events Related to Tirzepatide
por: Mishra, Rahul, et al.
Publicado: (2023)

Tirzepatide for type 2 diabetes
por: Anderson, Sarah L, et al.
Publicado: (2023)

Keeping patients with epilepsy safe: a surmountable challenge?
por: Shankar, Rohit, et al.
Publicado: (2015)

Surmounting structural barriers to tackle endemic infectious diseases
por: Calderón, Felix, et al.
Publicado: (2021)

The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against Obesity: STEP or SURPASS?
por: Jung, Han Na, et al.
Publicado: (2022)

Generalizability of the SURPASS‐2 Trial and Effect of Tirzepatide on US Diabetes and Obesity Control
por: Chiu, Nicholas, et al.
Publicado: (2022)

Tirzepatide and prevention of chronic kidney disease
por: Bosch, Catalina, et al.
Publicado: (2022)

Tirzepatide-Induced Injection Site Reaction
por: Mizumoto, Junki
Publicado: (2023)

Human biomonitoring data interpretation and ethics; obstacles or surmountable challenges?
por: Sepai, Ovnair, et al.
Publicado: (2008)

Baryon decay: flipped SU(5) surmounts another challenge
por: Ellis, Jonathan Richard, et al.
Publicado: (1990)

Surmounting Chemotherapy and Radioresistance in Chondrosarcoma: Molecular Mechanisms and Therapeutic Targets
por: Onishi, Anne C., et al.
Publicado: (2011)

Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
por: Kanwar, Jagat R, et al.
Publicado: (2012)

Repurposing Cardiac Glycosides: Drugs for Heart Failure Surmounting Viruses
por: Škubník, Jan, et al.
Publicado: (2021)

Efficacy and Safety of Ultra-Rapid Lispro in Younger and Older Patients with Type 2 Diabetes: Randomized Double-Blind PRONTO-T2D Study
por: Zhang, Qianyi, et al.
Publicado: (2022)

Tirzepatide—Friend or Foe in Diabetic Cancer Patients?
por: Samuel, Samson Mathews, et al.
Publicado: (2022)

Structural determinants of dual incretin receptor agonism by tirzepatide
por: Sun, Bingfa, et al.
Publicado: (2022)

Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
por: Donnadieu, Emmanuel, et al.
Publicado: (2020)

Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins
por: Feng, Yiyuan, et al.
Publicado: (2023)

Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review
por: Chavda, Vivek P., et al.
Publicado: (2022)

Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
por: Wang, Lijing
Publicado: (2022)

The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
por: Anala, Alekya Devi, et al.
Publicado: (2023)

Epidemiological Data on Heart Rhythm Disorders in India - A Formidable but Surmountable Challenge
por: Hygriv Rao, B
Publicado: (2012)

Successfully Climbing the “STAIRs”: Surmounting Failed Translation of Experimental Ischemic Stroke Treatments
por: Kahle, Michael P., et al.
Publicado: (2012)

Surmounting intrinsic quantum-measurement uncertainties in Gaussian-state tomography with quadrature squeezing
por: Řeháček, Jaroslav, et al.
Publicado: (2015)

Poor-Law Infirmaries in War-Time: How Difficulties Have Been Surmounted
Publicado: (1915)

Immune Suppression in Tumors as a Surmountable Obstacle to Clinical Efficacy of Cancer Vaccines
por: Wieërs, Grégoire, et al.
Publicado: (2011)

The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity
por: Lempesis, Ioannis G., et al.
Publicado: (2022)

Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program
por: Perreault, Leigh, et al.
Publicado: (2022)

Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes
por: Heise, Tim, et al.
Publicado: (2023)

Fasting and postprandial plasma glucose contribution to glycated haemoglobin and time in range in people with type 2 diabetes on basal and bolus insulin therapy: Results from a pooled analysis of insulin lispro clinical trials
por: Liao, Birong, et al.
Publicado: (2021)

Weight loss efficiency and safety of tirzepatide: A Systematic review
por: Lin, Fei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h6mt9qlf6hhvfrc2bplcri2q37